dr perricone acyl-glutathione eye lid serum MD Essential Fx Eyelid Lift – DermStreet Betsy Johnson Necklace GHK-Cu Peptide Dosing | based formulations and commitment Size:M 8.5/W 10.5

dr perricone acyl-glutathione eye lid serum MD Essential Fx Eyelid Lift – DermStreet Betsy Johnson Necklace GHK-Cu Peptide Dosing | based formulations and commitment Size:M 8.5/W 10.5

GHK-Cu Peptide Dosing | PeptidesPower

Comparing Cagrilintide to Other Weight Management Therapies While several therapies exist for the treatment of obesity, cagrilintide stands out due to its unique dual receptor agonism

Betsy Johnson Necklace

Size:M 8.5/W 10.5

25 mg/day oral Tirzepatide 15 mg/week Retatrutide 12 mg/week Liraglutide 3.0 mg/day Factor Peak trial weight loss Semaglutide -14.9% at 68 wks (STEP 1) Tirzepatide -22.5% at 72 wks (SURMOUNT-1) Retatrutide -28.7% at 68 wks (TRIUMPH-4) Liraglutide -8% at 56 wks (SCALE) Factor FDA status (June 2026) Semaglutide Approved (T2D, obesity, CVD, MASH, CKD, oral) Tirzepatide Approved (T2D, obesity) Retatrutide Investigational - Phase 3 Liraglutide Approved (Saxenda obesity, Victoza T2D) Factor CV outcomes data Semaglutide Yes - SELECT (20% MACE drop) Tirzepatide SURPASS-CVOT ongoing Retatrutide TRIUMPH-3 ongoing Liraglutide Yes - LEADER (13% MACE drop) These compounds are not interchangeable

based formulations and commitment to delivering results that you can see and feel